Ming Tsao
Ming Tsao
Professor of Laboratory Medicine and Pathobiology, University of Toronto, Senior Scientist and Consultant Pathologist, Princess
Verified email at
Cited by
Cited by
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma
WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ...
Journal of thoracic oncology 6 (2), 244-285, 2011
Comprehensive molecular profiling of lung adenocarcinoma
Cancer Genome Atlas Research Network
Nature 511 (7511), 543, 2014
The landscape of somatic copy-number alteration across human cancers
R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ...
Nature 463 (7283), 899-905, 2010
The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification
WD Travis, E Brambilla, AG Nicholson, Y Yatabe, JHM Austin, ...
Journal of thoracic oncology 10 (9), 1243-1260, 2015
Comprehensive genomic characterization of squamous cell lung cancers
CGAR Network
Nature 489 (7417), 519-25, 2012
The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer
P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ...
Journal of Thoracic Oncology 11 (1), 39-51, 2016
Erlotinib in lung cancer—molecular and clinical predictors of outcome
MS Tsao, A Sakurada, JC Cutz, CQ Zhu, S Kamel-Reid, J Squire, ...
New England Journal of Medicine 353 (2), 133-144, 2005
Vinorelbine plus cisplatin vs. observation in resected non–small-cell lung cancer
T Winton, R Livingston, D Johnson, J Rigas, M Johnston, C Butts, ...
New England Journal of Medicine 352 (25), 2589-2597, 2005
International network of cancer genome projects
Data coordination centre Kasprzyk (Leader) Arek 1 Stein (Leader) Lincoln D ...
Nature 464 (7291), 993-998, 2010
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ...
Nature 491 (7424), 399-405, 2012
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
KP Hoeflich, J Luo, EA Rubie, MS Tsao, OU Jin, JR Woodgett
Nature 406 (6791), 86-90, 2000
Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American …
NI Lindeman, PT Cagle, DL Aisner, ME Arcila, MB Beasley, EH Bernicker, ...
Archives of pathology & laboratory medicine 142 (3), 321-346, 2018
Characterizing the cancer genome in lung adenocarcinoma
BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ...
Nature 450 (7171), 893-898, 2007
PD-L1 immunohistochemistry assays for lung cancer: results from phase 1 of the blueprint PD-L1 IHC assay comparison project
FR Hirsch, A McElhinny, D Stanforth, J Ranger-Moore, M Jansson, ...
Journal of Thoracic Oncology 12 (2), 208-222, 2017
Probability of cancer in pulmonary nodules detected on first screening CT
A McWilliams, MC Tammemagi, JR Mayo, H Roberts, G Liu, K Soghrati, ...
New England Journal of Medicine 369 (10), 910-919, 2013
Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
Nature medicine 14 (8), 822-827, 2008
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
AJ Bass, H Watanabe, CH Mermel, S Yu, S Perner, RG Verhaak, SY Kim, ...
Nature genetics 41 (11), 1238-1242, 2009
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
JD Campbell, A Alexandrov, J Kim, J Wala, AH Berger, CS Pedamallu, ...
Nature genetics 48 (6), 607-616, 2016
Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
CQ Zhu, G da Cunha Santos, K Ding, A Sakurada, JC Cutz, N Liu, ...
Journal of clinical oncology 26 (26), 4268-4275, 2008
An overview of the c-MET signaling pathway
SL Organ, MS Tsao
Therapeutic advances in medical oncology 3 (1_suppl), S7-S19, 2011
The system can't perform the operation now. Try again later.
Articles 1–20